Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

NCT05346419 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Postmenopausal Osteoporosis
Hypovitaminosis D
Hyperparathyroidism

Interventions

DRUG: Risedronate
DRUG: Vitamin D

Sponsor

Hospital Regional 1o de Octubre

Collaborators

[object Object]
[object Object]